title: Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.
abstract: To discern the possible spread of the Escherichia coli O25b:H4-ST131 clonal group in poultry and the zoonotic potential of avian strains, we made a retrospective search of our strain collection and compared the findings for those strains with the findings for current strains. Thus, we have characterized a collection of 19 avian O25b:H4-ST131 E. coli strains isolated from 1995 to 2010 which, interestingly, harbored the ibeA gene. Using this virulence gene as a criterion for selection, we compared those 19 avian strains with 33 human O25b:H4-ST131 ibeA-positive E. coli strains obtained from patients with extraintestinal infections (1993 to 2009). All 52 O25b:H4-ST131 ibeA-positive E. coli strains shared the fimH, kpsMII, malX, and usp genes but showed statistically significant differences in nine virulence factors, namely, papGIII, cdtB, sat, and kpsMII K5, which were associated with human strains, and iroN, kpsMII K1, cvaC, iss, and tsh, which were associated with strains of avian origin. The XbaI macrorestriction profiles of the 52 E. coli O25b:H4-ST131 ibeA-positive strains revealed 11 clusters (clusters I to XI) of >85% similarity, with four clusters including strains of human and avian origin. Cluster VII (90.9% similarity) grouped 10 strains (7 avian and 3 human strains) that mostly produced CTX-M-9 and that also shared the same virulence profile. Finally, we compared the macrorestriction profiles of the 12 CTX-M-9-producing O25b:H4-ST131 ibeA strains (7 avian and 5 human strains) identified among the 52 strains with those of 15 human O25b:H4-ST131 CTX-M-14-, CTX-M-15-, and CTX-M-32-producing strains that proved to be negative for ibeA and showed that they clearly differed in the level of similarity from the CTX-M-9-producing strains. In conclusion, E. coli clonal group O25b:H4-ST131 ibeA has recently emerged among avian isolates with the new acquisition of the K1 capsule antigen and includes CTX-M-9-producing strains. This clonal group represents a real zoonotic risk that has crossed the barrier between human and avian hosts.
authors.affiliation: Departamento de Microbioloxía e Parasitoloxía, Facultade de Veterinaria, LREC, Universidade de Santiago de Compostela (USC), 27002 Lugo, Spain.
authors.forename: Azucena
authors.initials: A
authors.lastname: Mora
authors.forename: Alexandra
authors.initials: A
authors.lastname: Herrera
authors.forename: Rosalia
authors.initials: R
authors.lastname: Mamani
authors.forename: Cecilia
authors.initials: C
authors.lastname: López
authors.forename: María Pilar
authors.initials: MP
authors.lastname: Alonso
authors.forename: Jesús E
authors.initials: JE
authors.lastname: Blanco
authors.forename: Miguel
authors.initials: M
authors.lastname: Blanco
authors.forename: Ghizlane
authors.initials: G
authors.lastname: Dahbi
authors.forename: Fernando
authors.initials: F
authors.lastname: García-Garrote
authors.forename: Julia María
authors.initials: JM
authors.lastname: Pita
authors.forename: Amparo
authors.initials: A
authors.lastname: Coira
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Bernárdez
authors.forename: Jorge
authors.initials: J
authors.lastname: Blanco
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002645:Chickens / Q000382:microbiology; D004352:Drug Resistance, Microbial; D016521:Electrophoresis, Gel, Pulsed-Field; D004926:Escherichia coli / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000382:microbiology* / Q000662:veterinary; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism*; D005838:Genotype; D006801:Humans; D008826:Microbial Sensitivity Tests; D011201:Poultry Diseases / Q000382:microbiology; D012703:Serotyping / Q000662:veterinary; D014774:Virulence / Q000235:genetics; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; C412613:CTX-M-9 protein, E coli; D001618:beta-Lactamases
references.citation: BMC Microbiol. 2009 Jul 07;9:132
references.pmid: 19583828
references.citation: J Clin Microbiol. 2009 Nov;47(11):3721-5
references.pmid: 19710261
references.citation: Int J Antimicrob Agents. 2009 Aug;34(2):173-6
references.pmid: 19464856
references.citation: J Antimicrob Chemother. 2009 Aug;64(2):274-7
references.pmid: 19474064
references.citation: Antimicrob Agents Chemother. 2009 Jul;53(7):2846-51
references.pmid: 19380595
references.citation: Antimicrob Agents Chemother. 2004 Oct;48(10):3736-42
references.pmid: 15388428
references.citation: J Antimicrob Chemother. 2009 Jan;63(1):72-9
references.pmid: 19004839
references.citation: Clin Infect Dis. 2009 Jul 15;49(2):195-201
references.pmid: 19508167
references.citation: J Clin Microbiol. 2009 Dec;47(12):3968-79
references.pmid: 19828750
references.citation: J Antimicrob Chemother. 2008 Feb;61(2):273-81
references.pmid: 18077311
references.citation: J Infect Dis. 2007 Jul 15;196(2):297-303
references.pmid: 17570118
references.citation: Antimicrob Agents Chemother. 2003 Jul;47(7):2161-8
references.pmid: 12821463
references.citation: Int J Med Microbiol. 2005 Oct;295(6-7):383-404
references.pmid: 16238015
references.citation: Antimicrob Agents Chemother. 2009 Jan;53(1):327-8
references.pmid: 19001117
references.citation: Cell Microbiol. 2003 Apr;5(4):245-52
references.pmid: 12675682
references.citation: Emerg Infect Dis. 2010 Jan;16(1):88-95
references.pmid: 20031048
references.citation: Vet Microbiol. 1998 Mar 31;61(3):229-35
references.pmid: 9631534
references.citation: Int J Med Microbiol. 2007 Jun;297(3):163-76
references.pmid: 17374506
references.citation: J Antimicrob Chemother. 2009 Jun;63(6):1135-41
references.pmid: 19351692
references.citation: Antimicrob Agents Chemother. 2010 Jan;54(1):546-50
references.pmid: 19917759
references.citation: Vet Microbiol. 2002 Jan 23;84(3):231-41
references.pmid: 11731175
references.citation: Clin Microbiol Infect. 2008 Jan;14 Suppl 1:117-23
references.pmid: 18154535
references.citation: Emerg Infect Dis. 2008 Oct;14(10):1575-83
references.pmid: 18826822
references.citation: J Clin Microbiol. 2006 Oct;44(10):3484-92
references.pmid: 17021071
references.citation: Emerg Infect Dis. 2008 Feb;14(2):195-200
references.pmid: 18258110
references.citation: Appl Environ Microbiol. 2010 May;76(9):2799-805
references.pmid: 20228098
references.citation: Vet Res. 1999 Mar-Jun;30(2-3):299-316
references.pmid: 10367360
references.citation: J Clin Microbiol. 2007 Oct;45(10):3366-76
references.pmid: 17652485
references.citation: Appl Environ Microbiol. 2000 Oct;66(10):4555-8
references.pmid: 11010916
references.citation: Microbiology (Reading). 2005 Apr;151(Pt 4):1179-1186
references.pmid: 15817785
references.citation: J Antimicrob Chemother. 2010 Apr;65(4):651-60
references.pmid: 20118165
references.citation: J Clin Microbiol. 2008 Dec;46(12):3900-5
references.pmid: 18842941
references.citation: J Clin Microbiol. 2008 Aug;46(8):2605-12
references.pmid: 18579721
references.citation: J Med Microbiol. 1990 Mar;31(3):175-83
references.pmid: 1968978
references.citation: Int J Antimicrob Agents. 2010 Apr;35(4):316-21
references.pmid: 20060273
references.citation: J Clin Microbiol. 1995 Sep;33(9):2233-9
references.pmid: 7494007
references.citation: Antimicrob Agents Chemother. 2009 Jul;53(7):2733-9
references.pmid: 19398649
references.citation: J Infect Dis. 2002 Dec 1;186 Suppl 2:S220-4
references.pmid: 12424701
references.citation: Rev Infect Dis. 1988 Jul-Aug;10(4):867-78
references.pmid: 3263690